Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Dr. A. Velumani, CEO of Thyrocare, sparked debate by choosing a cab over a luxury car, emphasizing his frugal lifestyle. Detailing his journey from village life to business success, he credits ...

Viking Therapeutics, Inc. (VKTX) closed at $33.69 in the latest trading session, marking a +0.78% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The outgoing CEO, Dr Manabe, has been credited with pioneering advances in the development of antibody-drug conjugates, leading to licensing deals and the approvals of two precision cancer medicines, ...

Julien Grogg, CEO GENEVA ... “We are grateful to Dr. Mehrling for his valuable contributions in establishing a strong foundation for Release Therapeutics and wish him every success in his ...

In the last reported quarter, Viking reported an earnings surprise of 8.33%. Per our proven model, companies with the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), #2 ...

Future PLC said it appointed Kevin Li Ying as chief executive officer effective from March 31. The U.K. magazine publisher on Thursday said Li Ying joined the company more than 20 years ago and ...

Jeremy will ensure Hana is leveraging cutting-edge innovations and scanning the horizon for tomorrow’s innovations to further its mission,” said Dr. John Erdmann, President and CEO.